Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Simplicity Wealth LLC

Simplicity Wealth LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 108.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,389 shares of the medical equipment provider’s stock after purchasing an additional 724 shares during the period. Simplicity Wealth LLC’s holdings in Intuitive Surgical were worth $688,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in the business. Norges Bank bought a new position in Intuitive Surgical during the 4th quarter worth $2,401,493,000. GAMMA Investing LLC grew its stake in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares in the last quarter. Proficio Capital Partners LLC grew its stake in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. Capital Research Global Investors grew its stake in shares of Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after purchasing an additional 687,906 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth $313,769,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 1.4%

Intuitive Surgical stock opened at $522.41 on Thursday. Intuitive Surgical, Inc. has a 12 month low of $413.82 and a 12 month high of $616.00. The stock’s 50 day moving average is $524.49 and its 200-day moving average is $538.83. The company has a market capitalization of $187.24 billion, a price-to-earnings ratio of 81.50, a PEG ratio of 5.85 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the business posted $1.50 earnings per share. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Evercore ISI decreased their target price on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 target price on Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Truist Financial decreased their target price on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research note on Wednesday, April 23rd. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a report on Thursday, April 24th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Thursday, June 5th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $588.95.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 216 shares of the stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the sale, the director now owns 6,371 shares of the company’s stock, valued at $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.